New drug combo shows promise for hard-to-treat lymphoma
Disease control
Recruiting now
This study tests a combination of the immunotherapy drug epcoritamab with standard chemotherapy (GDP) in 32 adults whose large B-cell lymphoma has returned or not responded to treatment. The goal is to see if the combo can shrink tumors enough to allow for a stem cell transplant …
Phase: PHASE2 • Sponsor: Dipenkumar Modi • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC